Procurement contracts for COVID-19 vaccines

Contracts for the procurement of COVID-19 vaccines are disclosed here once negotiations with the manufacturers have been concluded.

To protect the population, the federal government procured vaccines from different manufacturers at an early stage. It was thus able to give members of the Swiss public quick access to safe, effective COVID-19 vaccines. The main emphasis was on mRNA vaccines, supplemented with other vaccines.

The contracts for the procurement of COVID-19 vaccines are disclosed in line with the requirements of the Federal Freedom of Information Act (FoIA/BGö/LTrans), which protects the manufacturers’ professional, trade and manufacturing secrets. These include details of their business strategy or the calculation of prices. This information has been blacked out in the documents.

All contracts and agreements are written in English and are  only available in that language.

Contracts

Moderna Switzerland GmbH

Agreement Date concluded Document
Memorandum of Understanding 09.06.2020 Download (PDF, 3 MB, 27.07.2022)
Agreement 05.08.2020 Download (PDF, 2 MB, 27.07.2022)
Parent Guarantee Agreement 05.08.2020 Download (PDF, 607 kB, 27.07.2022)
First Amendment 04.12.2020 Download (PDF, 1 MB, 27.07.2022)
Amended Parent Guarantee Agreement 04.12.2020 Download (PDF, 646 kB, 27.07.2022)
Second Amendment 02.02.2021 Download (PDF, 1018 kB, 27.07.2022)
Third Amendment 05.05.2021 Download (PDF, 560 kB, 27.07.2022)
Purchase Contract No 1 05.05.2021 Download (PDF, 2 MB, 27.07.2022)
Purchase Contract No 1 Parent Guarantee Agreement 05.05.2021 Download (PDF, 584 kB, 27.07.2022)
Fourth Amendment 18.03.2022 Download (PDF, 869 kB, 27.07.2022)
Purchase Contract No 2 18.03.2022 Download (PDF, 6 MB, 27.07.2022)

Pfizer AG

Agreement Date concluded Document
Head of Terms 12.10.2020 Download (PDF, 3 MB, 27.07.2022)
Manufacturing and Supply Agreement 01.12.2020 Download (PDF, 30 MB, 02.08.2022)
Amendment to Manufacturing and Supply Agreement 08.03.2021 Download (PDF, 1 MB, 27.07.2022)
Second Amendment to Manufacturing and Supply Agreement 23.08.2021 Download (PDF, 3 MB, 27.07.2022)
Third Amendment to Manufacturing and Supply Agreement 22.12.2021 Download (PDF, 1 MB, 27.07.2022)
Shipping and Handling Guidelines 22.12.2021 Download (PDF, 17 MB, 27.07.2022)

Novavax Inc. USA

Agreement Date concluded Document
Head of Terms 11./12.01.2021 Download (PDF, 4 MB, 27.07.2022)
Advance Purchase Agreement 03.12.2021 Download (PDF, 7 MB, 27.07.2022)
Accession Agreement 03.12.2021 Download (PDF, 2 MB, 27.07.2022)

Janssen Pharmaceutica NV

Agreement Date concluded Document
Bilateral Agreement Frankreich – Schweiz 28.09.2021 Download (PDF, 9 MB, 28.07.2022)
Supplemental Agreement Janssen – Schweiz 24.09.2021 Download (PDF, 6 MB, 28.07.2022)
Letter Consent to envisaged resale 27.09.2021 Download (PDF, 222 kB, 28.07.2022)

AstraZeneca AG

Agreement Date concluded Document
Advance Purchase Agreement Schweden -AstraZeneca - Schweiz 15.10.2020 Download (PDF, 3 MB, 28.07.2022)
Resell Agreement Schweden - Schweiz 15.10.2020 Download (PDF, 1 MB, 28.07.2022)

CureVac Corporate Services GmbH

Agreement Date concluded Document
Three-Party Agreement Schweden – Curevac - Schweiz 03.02.2021 Download (PDF, 3 MB, 28.07.2022)
Resell Agreement Schweden - Schweiz 03.02.2021 Download (PDF, 6 MB, 28.07.2022)

Last modification 13.09.2023

Top of page

Contact

Federal Office of Public Health FOPH
Legal Affairs Division
Schwarzenburgstrasse 157
3003 Bern
Switzerland
E-Mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/krankheiten/krankheiten-im-ueberblick/coronavirus/covid-19/bisherige-materialien/beschaffungsvertraege-covid-19-impfstoffe.html